Showing results (71-80 of 99) with videos related to
Sort By:
Pageof 10
Immuno-Oncology Technology|July 31, 2023
Rational engineering of an improved adenosine deaminase 2 enzyme for weaponizing T-cell therapiesJ R Cox, M Jennings, C Lenahan, et al.Immuno-Oncology Technology|June 15, 2026
Th17-mediated antitumor immunity in patient-derived organoid and autologous immune cell cocultures predicts response to immunotherapy in head and neck cancerP Meißner, P Kaps, T Momper, et al.Immuno-Oncology Technology|July 22, 2022
MART-1 TCR gene-modified peripheral blood T cells for the treatment of metastatic melanoma: a phase I/IIa clinical trialM W Rohaan, R Gomez-Eerland, J H van den Berg, et al.Immuno-Oncology Technology|June 27, 2022
Sprayable gel for postsurgical immunotherapyQian Chen, Tianyuan Ci, Zhen GuImmuno-Oncology Technology|June 27, 2022
Germline genetic host factors as predictive biomarkers in immuno-oncologyVylyny Chat, Robert Ferguson, Tomas KirchhoffImmuno-Oncology Technology|June 27, 2022
Development and applications of computer image analysis algorithms for scoring of PD-L1 immunohistochemistryL J Inge, E DennisImmuno-Oncology Technology|June 27, 2022
Immune checkpoints in thymic epithelial tumors: challenges and opportunitiesNicolas GirardImmuno-Oncology Technology|June 27, 2022
Microbiome-based interventions: therapeutic strategies in cancer immunotherapyC Soto Chervin, T F GajewskiImmuno-Oncology Technology|June 27, 2022
CD47-SIRPα-targeted therapeutics: status and prospectsR Maute, J Xu, I L WeissmanImmuno-Oncology Technology|June 27, 2022
Tumour mutational burden: primary versus metastatic tissue creates systematic biasDesiree Schnidrig, Samra Turajlic, Kevin LitchfieldPageof 10